Aster DM Healthcare to acquire 13 per cent stake in 254-bed Aster Aadhar Hospital

Published On 2024-11-28 07:15 GMT   |   Update On 2024-11-28 07:15 GMT
Advertisement

Bangalore: Aster DM Healthcare, one of the largest integrated healthcare providers in India, has entered into an agreement to acquire the balance stake in Aster Adhaar Hospital (Prerana Hospital Limited) in Kolhapur, Maharashtra.

With this acquisition, Aster DM Healthcare will own 100% of the target company, from the 87% stake it previously held. The transaction will be completed in two tranches and the indicative time period for completion of the acquisition is December 31, 2025. The complete acquisition of Prerana Hospital Limited marks a significant milestone for Aster DM Healthcare in its continued growth and diversification strategy.

Advertisement

The 254-bedded Aster Aadhar Hospital, Kolhapur is the city’s most comprehensive multi-speciality hospital. It is the first hospital in the region to acquire the prestigious NABH Accreditation— the gold standard for quality healthcare. With 25+ specialities offered along with a panel of leading doctors and dedicated support staff, the hospital puts compassionate, quality care at the forefront.

Also Read:Aster DM Healthcare to invest Rs 250 crore in CMI Hospital, plans to add 350 beds

Dr Azad Moopen, Founder & Chairman of Aster DM Healthcare, said, “The complete acquisition aligns perfectly with our strategic goals to consolidate our presence in Western India. The expansion will also further build our customer base and deliver greater value to all stakeholders. The Aster Aadhar Hospital is a key step in accelerating our growth and innovation in healthcare in this region especially in the wake of significant competitive presence of healthcare establishments here.”

Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. Over the next 5 years i.e. FY25-FY29, the India business is set to achieve CAGR ~18% - 20% YoY growth driven by an increased occupancy and addition of capacity. The Operating EBITDA margin is expected to reach a level of ~23%-25% over the next 4-5 years.

The subsidiary will operate and leverage the parent company's strengths, including its established market presence and financial stability, to consolidate growth and capture new opportunities. 

Also Read:Aster DM Healthcare expands footprints in South India, rebrands Ramesh Hospitals to Aster Ramesh Hospitals

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News